Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wort (London, United Kingdom), C. Favoccia (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), C. Mccabe (London, United Kingdom), K. Dimopoulos (London, United Kingdom). emPHasis-10 score predicts mortality in patients with pulmonary hypertension. 273

Member's Comments

No comment yet.

Related content which might interest you: MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017 Year: 2018 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Elevated pulmonary vascular resistance predicts mortality in COPD patients Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021 Year: 2021 The cardiovascular  comorbidity and the risk of stroke by means of CHADS2- VASc scale  in patients with chronic obstructive pulmonary disease. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 CT predictors of pulmonary hypertension in patients with severe COPD Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 549-555 Year: 2010 A clinical scoring algorithm to predict all cause mortality in COPD Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017 Year: 2018 Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Exercise ventilatory inefficiency is an independent predictor of mortality in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension Source: ERJ Open Res, 8 (1) 00006-2022; 10.1183/23120541.00006-2022 Year: 2022 Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019